Reuters US Business

GSK raises 2024 profit forecast but says sales growth to slow in 2nd half

By Eva Mathews (Reuters) -GSK raised its full-year profit forecast on Wednesday on strong demand for vaccines and specialty medicines though it noted sales growth would slow in the second half. CEO Emma Walmsley’s strategy has focussed on vaccines and infectious diseases and a shift in its HIV focus to long-acting treatment and prevention therapies. …

GSK raises 2024 profit forecast but says sales growth to slow in 2nd half Read More »

Musk disbands Tesla EV charging team, leaving customers in the dark

By Joseph White, Akash Sriram and Nora Eckert DETROIT (Reuters) -Elon Musk’s abrupt decision to lay off employees who ran Tesla’s electric vehicle charging business blindsided automakers gearing up to equip new EVs for customers to use the Tesla Supercharger network, industry officials and analysts said on Tuesday. For now, General Motors, Ford and other …

Musk disbands Tesla EV charging team, leaving customers in the dark Read More »

Britain’s Next keeps profit guidance after first-quarter sales rise

By James Davey LONDON (Reuters) -British clothing retailer Next on Wednesday kept its forecast for annual profit after reporting a 5.7% rise in first-quarter full price sales, slightly ahead of its guidance. With more than 800 stores in the UK and Ireland and nearly 8 million online customers, Next is often considered a gauge of …

Britain’s Next keeps profit guidance after first-quarter sales rise Read More »

OpenAI’s ChatGPT targeted in Austrian privacy complaint

By Foo Yun Chee BRUSSELS (Reuters) – Microsoft-backed startup OpenAI on Monday found itself the target of a privacy complaint by advocacy group NOYB for allegedly not fixing incorrect information provided by its generative AI chatbot ChatGPT that may breach EU privacy rules. ChatGPT, which kickstarted the GenAI boom in late 2022, can mimic human …

OpenAI’s ChatGPT targeted in Austrian privacy complaint Read More »

Ex-McKinsey partner sues firm, claims he was made opioids ‘scapegoat’

By Nate Raymond (Reuters) – A former McKinsey & Co partner sued the global consulting firm on Friday and accused it of defaming him and making him a “scapegoat” to distract attention from its work advising OxyContin maker Purdue Pharma and other manufacturers of opioid pain medications. Arnab Ghatak, who was fired in 2021, filed …

Ex-McKinsey partner sues firm, claims he was made opioids ‘scapegoat’ Read More »

US regulators seize troubled lender Republic First, sell it to Fulton Bank

(Reuters) -U.S. regulators have seized Republic First Bancorp and agreed to sell it to Fulton Bank, underscoring the challenges facing regional banks a year after the collapse of three peers. Philadelphia-based Republic First, which had abandoned funding talks with a group of investors, was seized by the Pennsylvania Department of Banking and Securities. The Federal …

US regulators seize troubled lender Republic First, sell it to Fulton Bank Read More »

Wall Street shares close up as megacap tech stocks rally

By Chibuike Oguh NEW YORK (Reuters) -U.S. stocks closed higher on Friday, buoyed by a rally in megacap growth stocks following robust quarterly results from technology heavyweights Alphabet and Microsoft in addition to moderate inflation data. Investors cheered Alphabet’s first-ever dividend, its $70 billion stock buyback program, and better-than-expected first-quarter results. Its shares jumped 10% …

Wall Street shares close up as megacap tech stocks rally Read More »

Lofty US stocks leave investors punishing earnings disappointments

By Lewis Krauskopf NEW YORK (Reuters) – Richly valued U.S. stocks are leaving investors with little tolerance for disappointment, raising the stakes ahead of a week in which two more technology and growth giants are set to report. Strong reports from Microsoft and Google parent Alphabet on Thursday helped propel the S&P 500 to its …

Lofty US stocks leave investors punishing earnings disappointments Read More »

Close Bitnami banner
Bitnami